High-grade Serous Ovarian Carcinoma (HGSOC) Recruiting Phase 3 Trials for Docetaxel (DB01248)

Also known as: B. High Grade Serous Ovarian Cancer / Ovarian High Grade Serous Carcinoma / High-grade Serous Ovarian Cancer / High-grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Cancer / High Grade Ovarian Serous / High Grade Serous Ovarian

IndicationStatusPhase
DBCOND0140551 (High-grade Serous Ovarian Carcinoma (HGSOC))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05281471Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Treatment